CD161

Based on 1 reference(s) in Google Scholar 8 10 1

Axon 2776

CAS [1627716-22-6]

MF C26H21N5O2
MW 435.48

  • Purity: 98%
  • Soluble in DMSO

CD161

Description

CD161 is a potent, orally active and selective BET bromodomain inhibitor (Ki values of 8.2 nM and 1.4 nM for BRD4 BD1 and BD2, respectively). CD161 inhibits cell growth in acute leukemia cell lines and breast cancer cell lines. Moreover, CD161 has an excellent oral pharmacokinetic profile and, orally administered, effectively inhibits tumor growth in mice.

KEYWORDS: CD161 | supplier | BET inhibitor | CD-161 | CD 161 | CAS [1627716-22-6] | Histone | BET (BRD) | Inhibitor | Proteins | BRD4 | Leukemia | Breast Cancer | Bioavailable

Order
Size Unit Price Stock
5 mg €135.00 In Stock
25 mg €475.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €220.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...